Diabetology Ltd

Diabetology Limited
Private
Industry Biotechnology
Founded Jersey (November 13, 2002 (2002-11-13))
Headquarters Saint Helier, Jersey (registered office)
Key people
 Roger New (CSO)
Glen Travers
Products 2 in clinical development and 3 in pre-clinical development
Website www.diabetology.co.uk

Diabetology Ltd is a biopharmaceutical company founded in 2002 and registered in Saint Helier, Jersey.[1]

They are currently developing oral drugs for the treatment of diabetes mellitus.[2]

Products

Currently, the company doesn't have a marketed product, though its pipeline includes one drug that has recently completed phase II clinical development, one in phase II clinical development, and three in pre-clinical development.[3]

Drug Phase Action
Capsulin OAD Phase II clinical trial completed Oral insulin for diabetes mellitus type 2
Capsulin IR Phase II clinical trial Oral insulin for diabetes mellitus type 1
Combulin Pre-clinical development Oral combination of insulin and insulin sensitizing agents for diabetes mellitus type 2
Oral GLP-1 Pre-clinical development Improves glycaemic and diet control in diabetes mellitus type 2
Oral C-Petdide Pre-clinical development Reduces diabetic complications

References

  1. ↑ https://www.jerseyfsc.org/registry/documentsearch/NameDetail.aspx?id=46021
  2. ↑ BBC NEWS
  3. ↑ Diabetology Ltd - Clinical pipeline


This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.